Association of the +33371 A/G polymorphism in adiponectin receptor 2 gene with Type 2 diabetes in the Chinese population

Journal of Endocrinological Investigation

Volumn 30, Issue 10, 2007, Pages 860-864

  Liao, Y F ^a   Chen, L L ^a   Zeng, T S ^a   Zheng, J ^a   Li, H Q ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adiponectin receptor 2; Insulin resistance; Polymorphism; Type 2 diabetes

Indexed keywords

ADENINE; ADIPONECTIN RECEPTOR 2; CHOLESTEROL; GLUCOSE; GUANINE; INSULIN; TRIACYLGLYCEROL; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 2, HUMAN; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHINESE; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; ASIAN; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK; RISK FACTOR;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ADIPONECTIN; RISK FACTORS;

EID: 38449094593     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349228     Document Type: Article

References (14)

1. Berg AH, Combs TP, Scherer FE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002, 13:84-9.
2. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002,8:731-7.
3. Heilbronn LK, Smith SR, Ravussin E. The insulin-sensitizing role of the fat derived hormone adiponectin. Curr Pharm Des 2003,9:1411-8.
4. Yamauchi T, Kamon J, Ito Y et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-9.
5. Civitarese AE, Jenkinson CP, Richardson DK, et al. Adiponectin receptors gene expression and insulin sensitivity in nondiabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia 2004,47:816-20.
6. Gil-Campos M, Canete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004, 23:963-74.
7. Yamauchi T, Kamon J, Minokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288-95.
8. Damcott CM, Ott SH, Pollin TI, et al. Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the Old Order Amish. Diabetes 2005, 54:2245-50.
9. Richardson DK, Schneider J, Fourcaudot MJ, et al. Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans. Diabetologia 2006, 49:23 17-28.
10. Vaxillaire M, Dechaume A, Vasseur-Delannoy V, et al. Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms fortype 2 diabetes in the Caucasian population. Diabetes 2006, 55:856-61.
11. Hara K, Horikoshi M, Kitazato H, et al. Absence of an association between the polymorphisms in the genes encoding adiponectin receptors and type 2 diabetes. Diabetologia 2005, 48:1307-14.
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20:1183-97.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-9.
14. Debard C, Laville M, Berbe V, et al. Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of type 2 diabetic patients. Diabetologia 2004,47:917-25.